Author: Dr. Paramesh Banerji
* Each > represents and expression of the fact that the patient is 25% better than the when she/he started the treatment with us.
Hypothyroidism like most other endocryinological (hormonal) disorders cannot be viewed in isolation. It should be viewed as a derrangement in the harmony of the entire hormonal balance of the person.
Our treatment works towards restoring this balance and leaves behind a permanent correction in the system. This is seen from the fact that even after discontinuing our treatment the patient does not return to the diseased condition.
All the symptoms of hypothyroidism begins to heal and subsequently the blood chemistry picture also gradually becomes normal. Subsequently, when we feel that the conditions are right - irrespective of the Blood chemistry - we discontinue our medicines. The symptoms do not resurface in almost all the cases and the improvements in the blood chemistry continues. This is due to the permanent nature of the correction our medicines are able to leave behind in the patient.
This is a quite a common illness and is caused by inefficiencies of Thyroid
The most common symptoms exhibited by patients of Hypothyroidism are tiredness, Sleep disorders which in some cases may lead to inability to sleep properly (insomnia) and in other cases may lead to lethargy to the level that makes a patient dose off in the midst of a conversation,palpitation, dryness of skin, body weight imbalance, hair loss, etc.
The only treatment available for this ailment in conventional medicine is Hormone Replacement Therapy (HRT). Which in simple terms compensates the shortage of the hormone that the Thyroid gland is unable to produce - similar to a food supplement.
This is not only not a solution and results in a lifelong treatment for the patient but actually a lot harmful.Hundreds of scientific studies have suggested the link between Hormone Replacement Therapies (like in the case of Hypothyroidism) and several warnings have been issued by Government health departments in Europe and North America.
Hormone replacement therapy increases the risk of stroke by almost a third, a review of clinical trials says. - BBC News, 7th January, 2005